Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Slakter

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Retina (Philadelphia, Pa.)|June 26, 2003
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot studyLawrence A Yannuzzi, Jason S Slakter, Nicole E Gross, et al.
Retina (Philadelphia, Pa.)|February 15, 2011
Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusionLouis K Chang, Richard F Spaide, James M Klancnik, et al.
Retina (Philadelphia, Pa.)|March 28, 2012
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003Lawrence A Yannuzzi, Jason S Slakter, Nicole E Gross, et al.
Ophthalmology|September 12, 2014
Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Jason S Slakter, et al.
Ophthalmology|March 16, 2013
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Peter K Kaiser, et al.
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
American Journal of Ophthalmology|November 27, 2007
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO StudyPhilip J Rosenfeld, David S Boyer, Neil M Bressler, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapyLuiz H Lima, Sandrine A Zweifel, Michael Engelbert, et al.
American Journal of Ophthalmology|January 29, 2002
Verteporfin infusion-associated painNatalie Borodoker, Richard F Spaide, Leandro Maranan, et al.
Retina (Philadelphia, Pa.)|May 15, 2013
Multifocal choroiditis without panuveitis: clinical characteristics and progressionAdrian T Fung, Samriti Pal, Nicolas A Yannuzzi, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Retina (Philadelphia, Pa.)|June 26, 2003
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot studyLawrence A Yannuzzi, Jason S Slakter, Nicole E Gross, et al.
Retina (Philadelphia, Pa.)|February 15, 2011
Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusionLouis K Chang, Richard F Spaide, James M Klancnik, et al.
Retina (Philadelphia, Pa.)|March 28, 2012
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003Lawrence A Yannuzzi, Jason S Slakter, Nicole E Gross, et al.
Ophthalmology|September 12, 2014
Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Jason S Slakter, et al.
Ophthalmology|March 16, 2013
Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID studyTimothy L Jackson, Usha Chakravarthy, Peter K Kaiser, et al.
JAMA Ophthalmology|June 2, 2017
Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation StudyTimothy L Jackson, David Boyer, David M Brown, et al.
American Journal of Ophthalmology|November 27, 2007
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO StudyPhilip J Rosenfeld, David S Boyer, Neil M Bressler, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapyLuiz H Lima, Sandrine A Zweifel, Michael Engelbert, et al.
American Journal of Ophthalmology|January 29, 2002
Verteporfin infusion-associated painNatalie Borodoker, Richard F Spaide, Leandro Maranan, et al.
Retina (Philadelphia, Pa.)|May 15, 2013
Multifocal choroiditis without panuveitis: clinical characteristics and progressionAdrian T Fung, Samriti Pal, Nicolas A Yannuzzi, et al.
Pageof 7